Skip to main content
. 2023 May 29;14:1182260. doi: 10.3389/fendo.2023.1182260

Table 3.

Comparison of behavioral questionnaires at baseline visit to 10 day and 3 month follow up.

Survey Baseline 10 Days 3 months
N Mean (SD) N Mean (SD) p-value b N Mean (SD) p-value b
Perceived Benefits of CGM Scale (BenCGM) 41 4.1 (0.7) 23 4.1 (1) 0.67 20 3.8 (1) 0.25
Perceived Barriers of CGM Scale (BurCGM) 41 1.95 (0.7) 23 1.8 (0.7) 0.40 20 1.97 (0.8) 0.76
PedsQL 3.2 Diabetes Module 40 71.1 (15.9) 22 70.3 (17.3) 0.61 20 70.5 (15.9) 0.51
Diabetes Distress Scale (DDS)a 37 1.9 (1.2-2.5) 23 1.4 (1-2.6) 0.68 20 1.8 (1.2-2.6) 0.64
DDS - Emotional burden subscore 37 2 (1.2-3.6) 23 1.6 (1-2.6) 0.89 20 1.7 (1.1-3.5) 0.79
DDS - Physician related distress 37 1 (1-2.3) 23 1 (1-1) 0.25 20 1 (1-2) 0.37
DDS - Regiment related distress 37 1.6 (1.2-2.8) 23 1.4 (1-3.6) 0.19 20 2.3 (1.3-3.5) 0.21
DDS Interpersonal Distress 37 1 (1-1.7) 23 1 (1-1.7) 0.18 20 1 (1-1.5) 0.031
The Glucose Monitoring Satisfaction Survey Type 2 Diabetes (GMSS-T2D) 39 3.8 (0.6) 22 3.8 (0.6) 0.69 19 3.4 (0.6) 0.24
GMSS - Openness 41 3.4 (0.7) 23 3.1 (0.9) 0.12 20 3 (0.8) 0.43
GMSS - Emotional burden 41 2.2 (0.8) 23 2.2 (0.8) 0.38 20 2.6 (0.8) 0.051
GMSS - Behavioral burden 41 2 (0.8) 23 1.8 (0.8) 0.49 20 2.1 (0.7) 0.87
GMSS - Worth 39 3.9 (0.7) 22 4.1 (0.8) 0.34 19 3.5 (0.8) 0.35
a

DDS scores are not normally distributed. Median and IQR are reported.

b

Paired T-tests are used to calculate p values for all surveys except DDS and DDS sub-scales which use the Wilcoxon signed-rank test. Tests are conducted on subjects with both baseline and follow completed.

The bolded value is statistically significant p-value with p-value < 0.05.